{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T03:03:01Z","timestamp":1789095781156,"version":"build-2803163510"},"reference-count":137,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013373","name":"NIHR Oxford Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ophthalmologyscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Science"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.xops.2026.101287","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:59:48Z","timestamp":1781625588000},"page":"101287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Interactions Between Epidermal Growth Factor\u2013Containing Fibulin-Like Extracellular Matrix Protein 1 and Tissue Inhibitor of Metalloproteinases-3 and Relevance to Age-Related Macular Degeneration"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-5709-4923","authenticated-orcid":false,"given":"Clara","family":"Ehrenzeller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"MacLaren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10153","key":"10.1016\/j.xops.2026.101287_bib1","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0140-6736(18)31550-2","article-title":"Age-related macular degeneration","volume":"392","author":"Mitchell","year":"2018","journal-title":"The Lancet"},{"key":"10.1016\/j.xops.2026.101287_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1147037","article-title":"The extracellular microenvironment in immune dysregulation and inflammation in retinal disorders","volume":"14","author":"Biasella","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.xops.2026.101287_bib3","series-title":"Retinal Degenerative Diseases","first-page":"153","article-title":"Malattia Leventinese\/Doyne honeycomb retinal dystrophy: similarities to age-related macular degeneration and potential therapies","author":"Hulleman","year":"2016"},{"key":"10.1016\/j.xops.2026.101287_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2025.101358","article-title":"Characterizing Bruch's membrane: State-of-the-art imaging, computational segmentation, and biologic models in retinal disease and health","volume":"106","author":"Ong","year":"2025","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"10.1016\/j.xops.2026.101287_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2009.08.003","article-title":"The dynamic nature of Bruch's membrane","volume":"29","author":"Booij","year":"2010","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.xops.2026.101287_bib6","series-title":"Age-related Macular Degeneration: From Clinic to Genes and Back to Patient Management","first-page":"89","article-title":"Bruch\u2019s membrane and the choroid in age-related macular degeneration","author":"Edwards","year":"2021"},{"issue":"3","key":"10.1016\/j.xops.2026.101287_bib7","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3390\/cells10030687","article-title":"Cell\u2013Matrix interactions in the eye: from cornea to choroid","volume":"10","author":"Pouw","year":"2021","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.xops.2026.101287_bib8","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.3390\/biom15081059","article-title":"Extracellular Matrix (ECM) aging in the retina: the role of Matrix metalloproteinases (MMPs) in bruch's membrane pathology and Age-Related Macular Degeneration (AMD)","volume":"15","author":"Hussain","year":"2025","journal-title":"Biomolecules"},{"issue":"14","key":"10.1016\/j.xops.2026.101287_bib9","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1056\/NEJMra062326","article-title":"Age-Related macular degeneration","volume":"355","author":"Jong","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.xops.2026.101287_bib10","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.3389\/fimmu.2017.01778","article-title":"Bruch's membrane compartmentalizes complement regulation in the eye with implications for therapeutic design in age-related macular degeneration","volume":"8","author":"Clark","year":"2017","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.xops.2026.101287_bib11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/hmg\/ddx392","article-title":"Changes in extracellular matrix cause RPE cells to make basal deposits and activate the alternative complement pathway","volume":"27","author":"Fernandez-Godino","year":"2018","journal-title":"Hum Mol Genet"},{"issue":"20","key":"10.1016\/j.xops.2026.101287_bib12","doi-asserted-by":"crossref","first-page":"13067","DOI":"10.1073\/pnas.202491599","article-title":"Aberrant accumulation of EFEMP1 underlies drusen formation in Malattia Leventinese and age-related macular degeneration","volume":"99","author":"Marmorstein","year":"2002","journal-title":"Proc Natl Acad Sci"},{"issue":"11","key":"10.1016\/j.xops.2026.101287_bib13","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s00109-020-01974-z","article-title":"Fibulin-3 knockout mice demonstrate corneal dysfunction but maintain normal retinal integrity","volume":"98","author":"Daniel","year":"2020","journal-title":"J Mol Med"},{"key":"10.1016\/j.xops.2026.101287_bib14","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1080\/13816810.2025.2524511","article-title":"A review of the role of EFEMP1 in ophthalmic disease","volume":"46","author":"Wood","year":"2025","journal-title":"Ophthalmic Genet"},{"issue":"12","key":"10.1016\/j.xops.2026.101287_bib15","article-title":"Antisense oligonucleotide allele-specific targeting of EFEMP1 in a patient-derived model of Doyne honeycomb retinal dystrophy","volume":"37","author":"Rezek","year":"2026","journal-title":"Mol Ther Nucleic Acids"},{"issue":"6","key":"10.1016\/j.xops.2026.101287_bib16","article-title":"Exploring ocular fibulin-3 (EFEMP1): anatomical, age-related, and species perspectives","volume":"1870","author":"Daniel","year":"2024","journal-title":"Biochim Biophys Acta BBA - Mol Basis Dis"},{"issue":"9","key":"10.1016\/j.xops.2026.101287_bib17","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.3390\/biom10091294","article-title":"The pathophysiological significance of Fibulin-3","volume":"10","author":"Livingstone","year":"2020","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.xops.2026.101287_bib18","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/13816810490498305","article-title":"Association of EFEMP1 with malattia leventinese and age-related macular degeneration: a mini-review","volume":"25","author":"Marmorstein","year":"2004","journal-title":"Ophthalmic Genet"},{"issue":"10","key":"10.1016\/j.xops.2026.101287_bib19","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2217\/bmm-2018-0285","article-title":"Fibulin-3 as biomarker of malignant mesothelioma","volume":"13","author":"Ledda","year":"2019","journal-title":"Biomark Med"},{"issue":"24","key":"10.1016\/j.xops.2026.101287_bib20","doi-asserted-by":"crossref","first-page":"9739","DOI":"10.3390\/ijms21249739","article-title":"The roles of matrix metalloproteinases and their inhibitors in human diseases","volume":"21","author":"Cabral-Pacheco","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.xops.2026.101287_bib21","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.matbio.2015.03.005","article-title":"The role of TIMPs in regulation of extracellular matrix proteolysis","volume":"44\u201346","author":"Arpino","year":"2015","journal-title":"Matrix Biol"},{"issue":"2","key":"10.1016\/j.xops.2026.101287_bib22","doi-asserted-by":"crossref","first-page":"jcs261898","DOI":"10.1242\/jcs.261898","article-title":"Matrix metalloproteinases at a glance","volume":"137","author":"Hey","year":"2024","journal-title":"J Cell Sci"},{"issue":"24","key":"10.1016\/j.xops.2026.101287_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252413691","article-title":"The complex role of matrix Metalloproteinase-2 (MMP-2) in health and disease","volume":"25","author":"Wolosowicz","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"18","key":"10.1016\/j.xops.2026.101287_bib24","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.2174\/0929867329666220823112731","article-title":"Physiological properties, functions, and trends in the matrix metalloproteinase inhibitors in inflammation-mediated human diseases","volume":"30","author":"Kim","year":"2023","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.xops.2026.101287_bib25","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.matbio.2015.02.007","article-title":"Extracellular regulation of metalloproteinases","volume":"44\u201346","author":"Yamamoto","year":"2015","journal-title":"Matrix Biol"},{"issue":"8","key":"10.1016\/j.xops.2026.101287_bib26","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1161\/01.RES.0000070112.80711.3D","article-title":"Matrix metalloproteinases and tissue inhibitors of metalloproteinases","volume":"92","author":"Visse","year":"2003","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.xops.2026.101287_bib27","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1183\/09031936.00146510","article-title":"Biological role of matrix metalloproteinases: a critical balance","volume":"38","author":"L\u00f6ffek","year":"2011","journal-title":"Eur Respir J"},{"issue":"12","key":"10.1016\/j.xops.2026.101287_bib28","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1002\/jcp.25430","article-title":"Intricate functions of matrix metalloproteinases in physiological and pathological conditions","volume":"231","author":"Mittal","year":"2016","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.xops.2026.101287_bib29","series-title":"Retinal Degenerative Diseases XIX","first-page":"21","article-title":"Disturbed Matrix metalloproteinases activity in age-related macular degeneration","author":"Martins","year":"2023"},{"issue":"16","key":"10.1016\/j.xops.2026.101287_bib30","doi-asserted-by":"crossref","first-page":"5934","DOI":"10.3390\/ijms21165934","article-title":"Matrix metalloproteinases in Age-Related Macular Degeneration (AMD)","volume":"21","author":"Garc\u00eda-Onrubia","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.xops.2026.101287_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2019.100775","article-title":"Understanding the complexity of the matrix metalloproteinase system and its relevance to age-related diseases: Age-related macular degeneration and Alzheimer's disease","volume":"74","author":"Hussain","year":"2020","journal-title":"Prog Retin Eye Res"},{"issue":"11","key":"10.1016\/j.xops.2026.101287_bib32","first-page":"2676","article-title":"Age-Dependent variation in metalloproteinase activity of isolated human bruch's membrane and choroid","volume":"40","author":"Guo","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"22","key":"10.1016\/j.xops.2026.101287_bib33","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.15252\/embj.201591881","article-title":"Complement activation, regulation, and molecular basis for complement-related diseases","volume":"34","author":"Bajic","year":"2015","journal-title":"EMBO J"},{"issue":"12","key":"10.1016\/j.xops.2026.101287_bib34","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.addr.2011.06.005","article-title":"Complement in health and disease","volume":"63","author":"Carroll","year":"2011","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.xops.2026.101287_bib35","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3389\/fimmu.2015.00257","article-title":"Complement System part II: role in immunity","volume":"6","author":"Merle","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.xops.2026.101287_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.845953","article-title":"Complement factor H-Related proteins FHR1 and FHR5 interact with extracellular matrix ligands, reduce factor H regulatory activity and enhance complement activation","volume":"13","author":"Papp","year":"2022","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.xops.2026.101287_bib37","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/s41580-024-00767-3","article-title":"Mechanisms of assembly and remodeling of the extracellular matrix","volume":"25","author":"Naba","year":"2024","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"13","key":"10.1016\/j.xops.2026.101287_bib38","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1111\/febs.70292","article-title":"Extracellular matrix and proteolysis: mechanisms driving irreversible changes and shaping cell behavior","volume":"293","author":"Solomonov","year":"2025","journal-title":"FEBS J"},{"issue":"8","key":"10.1016\/j.xops.2026.101287_bib39","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.3390\/ijms23084256","article-title":"The role of metalloproteinases and their tissue inhibitors on ocular diseases: focusing on potential mechanisms","volume":"23","author":"Caban","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.xops.2026.101287_bib40","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.12659\/MSM.889887","article-title":"Age-related macular degeneration and changes in the extracellular matrix","volume":"20","author":"Romaniuk","year":"2014","journal-title":"Med Sci Monit"},{"issue":"23","key":"10.1016\/j.xops.2026.101287_bib41","doi-asserted-by":"crossref","first-page":"14682","DOI":"10.1073\/pnas.222551899","article-title":"Drusen proteome analysis: an approach to the etiology of age-related macular degeneration","volume":"99","author":"Crabb","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.xops.2026.101287_bib42","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/978-981-13-2835-0_7","article-title":"Extracellular Matrix and ageing","volume":"90","author":"Birch","year":"2018","journal-title":"Subcell Biochem"},{"issue":"3","key":"10.1016\/j.xops.2026.101287_bib43","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1042\/BST20230860","article-title":"Modification of extracellular matrix proteins by oxidants and electrophiles","volume":"52","author":"Yang-Jensen","year":"2024","journal-title":"Biochem Soc Trans"},{"issue":"70","key":"10.1016\/j.xops.2026.101287_bib44","article-title":"Fibroageing: an ageing pathological feature driven by dysregulated extracellular matrix-cell mechanobiology","volume":"1","author":"Selman","year":"2021","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.xops.2026.101287_bib45","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.freeradbiomed.2019.11.018","article-title":"Extracellular matrix and oxidative stress regulate human retinal pigment epithelium growth","volume":"146","author":"Eamegdool","year":"2020","journal-title":"Free Radic Biol Med"},{"issue":"6","key":"10.1016\/j.xops.2026.101287_bib46","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1006\/exer.1998.0552","article-title":"Increase in interphotoreceptor matrix gelatinase A (MMP-2) associated with age-related macular degeneration","volume":"67","author":"Plantner","year":"1998","journal-title":"Exp Eye Res"},{"issue":"9","key":"10.1016\/j.xops.2026.101287_bib47","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1167\/iovs.04-1224","article-title":"Nonlethal oxidant injury to human retinal pigment epithelium cells causes cell membrane blebbing but decreased MMP-2 activity","volume":"46","author":"Marin-Casta\u00f1o","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.xops.2026.101287_bib48","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1167\/iovs.09-4195","article-title":"Increased sequestration of matrix metalloproteinases in ageing human bruch's membrane: implications for ECM turnover","volume":"51","author":"Kumar","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.xops.2026.101287_bib49","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1006\/exer.2001.1112","article-title":"Drusen are cold spots for proteolysis: expression of matrix metalloproteinases and their tissue inhibitor proteins in age-related macular degeneration","volume":"74","author":"Leu","year":"2002","journal-title":"Exp Eye Res"},{"issue":"5","key":"10.1016\/j.xops.2026.101287_bib50","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.ajhg.2021.04.006","article-title":"Impaired cholesterol efflux in retinal pigment epithelium of individuals with juvenile macular degeneration","volume":"108","author":"Tsai","year":"2021","journal-title":"Am J Hum Genet"},{"issue":"30","key":"10.1016\/j.xops.2026.101287_bib51","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2103617118","article-title":"Chromosome 10q26\u2013driven age-related macular degeneration is associated with reduced levels of HTRA1 in human retinal pigment epithelium","volume":"118","author":"Williams","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.xops.2026.101287_bib52","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-3-319-75402-4_4","article-title":"Alterations in extracellular Matrix\/Bruch's membrane can cause the activation of the alternative complement pathway via tick-over","volume":"1074","author":"Fernandez-Godino","year":"2018","journal-title":"Adv Exp Med Biol"},{"issue":"5801","key":"10.1016\/j.xops.2026.101287_bib53","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1126\/science.1133811","article-title":"A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration","volume":"314","author":"Yang","year":"2006","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.xops.2026.101287_bib54","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s40123-021-00402-w","article-title":"Association of the HtrA1 rs11200638 polymorphism with neovascular age-related macular degeneration in Indonesia","volume":"11","author":"Supanji","year":"2022","journal-title":"Ophthalmol Ther"},{"issue":"5","key":"10.1016\/j.xops.2026.101287_bib55","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.visres.2007.10.022","article-title":"Further mapping of 10q26 supports strong association of HTRA1 polymorphisms with age-related macular degeneration","volume":"48","author":"Gibbs","year":"2008","journal-title":"Vision Res"},{"issue":"4","key":"10.1016\/j.xops.2026.101287_bib56","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12710","article-title":"HTRA1, an age-related macular degeneration protease, processes extracellular matrix proteins EFEMP1 and TSP1","volume":"17","author":"Lin","year":"2018","journal-title":"Aging Cell"},{"issue":"1","key":"10.1016\/j.xops.2026.101287_bib57","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12920-020-00760-7","article-title":"Genome-wide association meta-analysis for early age-related macular degeneration highlights novel loci and insights for advanced disease","volume":"13","author":"Winkler","year":"2020","journal-title":"BMC Med Genomics"},{"issue":"6","key":"10.1016\/j.xops.2026.101287_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068088","article-title":"Interaction of complement factor H and Fibulin3 in age-related macular degeneration","volume":"8","author":"Wyatt","year":"2013","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.xops.2026.101287_bib59","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/ng.3448","article-title":"A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants","volume":"48","author":"Fritsche","year":"2016","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.xops.2026.101287_bib60","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/hmg\/ddy002","article-title":"Genome-wide analysis of disease progression in age-related macular degeneration","volume":"27","author":"Yan","year":"2018","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.xops.2026.101287_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2021.100952","article-title":"Implications of genetic variation in the complement system in age-related macular degeneration","volume":"84","author":"de Jong","year":"2021","journal-title":"Prog Retin Eye Res"},{"issue":"12","key":"10.1016\/j.xops.2026.101287_bib62","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1038\/s41588-024-01764-0","article-title":"Genome-wide association analyses identify distinct genetic architectures for age-related macular degeneration across ancestries","volume":"56","author":"Gorman","year":"2024","journal-title":"Nat Genet"},{"key":"10.1016\/j.xops.2026.101287_bib63","doi-asserted-by":"crossref","DOI":"10.1038\/srep26568","article-title":"A novel complotype combination associates with age-related macular degeneration and high complement activation levels in vivo","volume":"6","author":"Paun","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.xops.2026.101287_bib64","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/hmg\/ddp472","article-title":"Genetic control of the alternative pathway of complement in humans and age-related macular degeneration","volume":"19","author":"Hecker","year":"2010","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.1016\/j.xops.2026.101287_bib65","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/s41588-019-0351-9","article-title":"Retinal transcriptome and eQTL analyses identify genes associated with age-related macular degeneration","volume":"51","author":"Ratnapriya","year":"2019","journal-title":"Nat Genet"},{"issue":"21","key":"10.1016\/j.xops.2026.101287_bib66","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.1093\/hmg\/ddac103","article-title":"Functional analysis of rare genetic variants in complement factor I in advanced age-related macular degeneration","volume":"31","author":"Java","year":"2022","journal-title":"Hum Mol Genet"},{"issue":"9","key":"10.1016\/j.xops.2026.101287_bib67","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/humu.24242","article-title":"Prevalence and phenotype associations of complement factor I mutations in geographic atrophy","volume":"42","author":"Khan","year":"2021","journal-title":"Hum Mutat"},{"issue":"4","key":"10.1016\/j.xops.2026.101287_bib68","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/ng.2578","article-title":"Seven new loci associated with age-related macular degeneration","volume":"45","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.xops.2026.101287_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2022.101154","article-title":"10q26 \u2013 the enigma in age-related macular degeneration","volume":"96","author":"Merle","year":"2023","journal-title":"Prog Retin Eye Res"},{"issue":"7","key":"10.1016\/j.xops.2026.101287_bib70","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.3390\/genes13071233","article-title":"Molecular genetic mechanisms in age-related macular degeneration","volume":"13","author":"Shughoury","year":"2022","journal-title":"Genes"},{"key":"10.1016\/j.xops.2026.101287_bib71","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-92351-4","article-title":"Epistatic interactions of genetic loci associated with age-related macular degeneration","volume":"11","author":"Kiel","year":"2021","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.xops.2026.101287_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022959","article-title":"Overexpression of HTRA1 leads to ultrastructural changes in the elastic layer of bruch's membrane via cleavage of extracellular matrix components","volume":"6","author":"Vierkotten","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.xops.2026.101287_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2022.101159","article-title":"Exploring the contribution of ARMS2 and HTRA1 genetic risk factors in age-related macular degeneration","volume":"97","author":"Pan","year":"2023","journal-title":"Prog Retin Eye Res"},{"issue":"10","key":"10.1016\/j.xops.2026.101287_bib74","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1089\/ars.2019.7962","article-title":"Mitochondrial superoxide dismutase: what the established, the intriguing, and the novel reveal about a key cellular redox switch","volume":"32","author":"Palma","year":"2020","journal-title":"Antioxid Redox Signal"},{"issue":"3","key":"10.1016\/j.xops.2026.101287_bib75","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1001\/jamaophthalmol.2021.6072","article-title":"Progression of age-related macular degeneration among individuals homozygous for risk alleles on chromosome 1 (CFH-CFHR5) or chromosome 10 (ARMS2\/HTRA1) or both","volume":"140","author":"Schmitz-Valckenberg","year":"2022","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.xops.2026.101287_bib76","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.preteyeres.2017.09.001","article-title":"Complement factor H in AMD: bridging genetic associations and pathobiology","volume":"62","author":"Toomey","year":"2018","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"10.1016\/j.xops.2026.101287_bib77","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/jcm4010018","article-title":"Role of factor H and related proteins in regulating complement activation in the macula, and relevance to age-related macular degeneration","volume":"4","author":"Clark","year":"2014","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.xops.2026.101287_bib78","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.bpj.2018.12.007","article-title":"Molecular mechanisms of macular degeneration associated with the complement factor H Y402H mutation","volume":"116","author":"Harrison","year":"2019","journal-title":"Biophys J"},{"issue":"2","key":"10.1016\/j.xops.2026.101287_bib79","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.survophthal.2020.10.008","article-title":"Revisiting the role of factor H in age-related macular degeneration: insights from complement-mediated renal disease and rare genetic variants","volume":"66","author":"Tzoumas","year":"2021","journal-title":"Surv Ophthalmol"},{"issue":"29","key":"10.1016\/j.xops.2026.101287_bib80","doi-asserted-by":"crossref","first-page":"30469","DOI":"10.1074\/jbc.M403026200","article-title":"Tissue inhibitor of Metalloproteinases-3 (TIMP-3) is a binding partner of epithelial growth factor-containing fibulin-like extracellular matrix protein 1 (EFEMP1)","volume":"279","author":"Klenotic","year":"2004","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.xops.2026.101287_bib81","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1167\/iovs.10-6678","article-title":"Disturbed Matrix metalloproteinase activity of bruch's membrane in age-related macular degeneration","volume":"52","author":"Hussain","year":"2011","journal-title":"Invest Opthalmol Vis Sci"},{"issue":"10","key":"10.1016\/j.xops.2026.101287_bib82","first-page":"2367","article-title":"TIMP-3 in bruch's membrane: changes during aging and in age-related macular degeneration","volume":"40","author":"Kamei","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.xops.2026.101287_bib83","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3390\/cells9010039","article-title":"The diverse roles of TIMP-3: insights into degenerative diseases of the senescent retina and brain","volume":"9","author":"Dewing","year":"2019","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.xops.2026.101287_bib84","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1097\/00001756-199707070-00015","article-title":"Localization of tissue inhibitor of metalloproteinases-3 in neurodegenerative retinal disease","volume":"8","author":"Jomary","year":"1997","journal-title":"NeuroReport"},{"issue":"5","key":"10.1016\/j.xops.2026.101287_bib85","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1167\/iovs.09-4259","article-title":"High molecular-weight gelatinase species of human bruch's membrane: compositional analyses and age-related changes","volume":"51","author":"Hussain","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"24","key":"10.1016\/j.xops.2026.101287_bib86","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1016\/j.devcel.2024.09.006","article-title":"Human iPSC-based disease modeling studies identify a common mechanistic defect and potential therapies for AMD and related macular dystrophies","volume":"59","author":"Dalvi","year":"2024","journal-title":"Dev Cell"},{"issue":"2","key":"10.1016\/j.xops.2026.101287_bib87","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.exer.2006.09.021","article-title":"Fibulin-5 distribution in human eyes: relevance to age-related macular degeneration","volume":"84","author":"Mullins","year":"2007","journal-title":"Exp Eye Res"},{"issue":"4","key":"10.1016\/j.xops.2026.101287_bib88","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1056\/NEJMoa040833","article-title":"Missense variations in the Fibulin 5 gene and age-related macular degeneration","volume":"351","author":"Stone","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.xops.2026.101287_bib89","first-page":"1003","article-title":"Age-related macular degeneration and changes in the extracellular matrix","volume":"20","author":"Nita","year":"2014","journal-title":"Med Sci Monit Int Med J Exp Clin Res"},{"issue":"1","key":"10.1016\/j.xops.2026.101287_bib90","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1001\/jamaophthalmol.2022.4602","article-title":"Associations of alzheimer disease\u2013protective APOE variants with age-related macular degeneration","volume":"141","author":"Rasmussen","year":"2023","journal-title":"JAMA Ophthalmol"},{"issue":"33","key":"10.1016\/j.xops.2026.101287_bib91","doi-asserted-by":"crossref","first-page":"11900","DOI":"10.1073\/pnas.0503015102","article-title":"Apolipoprotein E allele-dependent pathogenesis: a model for age-related retinal degeneration","volume":"102","author":"Malek","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.xops.2026.101287_bib92","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.cmet.2013.03.009","article-title":"Impaired cholesterol efflux in senescent macrophages promotes age-related macular degeneration","volume":"17","author":"Sene","year":"2013","journal-title":"Cell Metab"},{"key":"10.1016\/j.xops.2026.101287_bib93","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.45100","article-title":"Impaired ABCA1\/ABCG1-mediated lipid efflux in the mouse retinal pigment epithelium (RPE) leads to retinal degeneration","volume":"8","author":"Storti","year":"2019","journal-title":"eLife"},{"issue":"13","key":"10.1016\/j.xops.2026.101287_bib94","doi-asserted-by":"crossref","first-page":"6174","DOI":"10.3390\/ijms26136174","article-title":"Age-Related macular degeneration: cellular and molecular signaling mechanisms","volume":"26","author":"Jiang","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.xops.2026.101287_bib95","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/imr.13145","article-title":"Age-related macular degeneration: a disease of extracellular complement amplification","volume":"313","author":"de Jong","year":"2023","journal-title":"Immunol Rev"},{"issue":"6","key":"10.1016\/j.xops.2026.101287_bib96","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1056\/NEJMoa072618","article-title":"Complement C3 variant and the risk of age-related macular degeneration","volume":"357","author":"Yates","year":"2007","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.xops.2026.101287_bib97","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/jamaophthalmol.2016.4604","article-title":"The functional effect of rare variants in complement genes on C3b degradation in patients with age-related macular degeneration","volume":"135","author":"Geerlings","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.xops.2026.101287_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100858","article-title":"Mechanisms of mitochondrial dysfunction and their impact on age-related macular degeneration","volume":"79","author":"Kaarniranta","year":"2020","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"10.1016\/j.xops.2026.101287_bib99","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00439-010-0904-6","article-title":"Genome-wide analysis of copy number variants in age-related macular degeneration","volume":"129","author":"Meyer","year":"2011","journal-title":"Hum Genet"},{"issue":"3","key":"10.1016\/j.xops.2026.101287_bib100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152047","article-title":"Whole exome sequencing in patients with the cuticular Drusen subtype of age-related macular degeneration","volume":"11","author":"Duvvari","year":"2016","journal-title":"PLoS ONE"},{"issue":"10","key":"10.1016\/j.xops.2026.101287_bib101","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.3390\/antiox14101251","article-title":"Title oxidative stress in age-related macular degeneration: from molecular mechanisms to emerging therapeutic targets","volume":"14","author":"Mimura","year":"2025","journal-title":"Antioxidants"},{"key":"10.1016\/j.xops.2026.101287_bib102","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/978-3-319-17121-0_13","article-title":"Interrelation between oxidative stress and complement activation in models of age-related macular degeneration","volume":"854","author":"Pujol-Lereis","year":"2016","journal-title":"Adv Exp Med Biol"},{"issue":"18","key":"10.1016\/j.xops.2026.101287_bib103","doi-asserted-by":"crossref","first-page":"12753","DOI":"10.1074\/jbc.M112.421891","article-title":"Oxidative stress sensitizes Retinal Pigmented Epithelial (RPE) cells to complement-mediated injury in a natural Antibody-, Lectin Pathway-, and phospholipid epitope-dependent manner","volume":"288","author":"Joseph","year":"2013","journal-title":"J Biol Chem"},{"issue":"10386","key":"10.1016\/j.xops.2026.101287_bib104","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0140-6736(22)02609-5","article-title":"Age-related macular degeneration","volume":"401","author":"Guymer","year":"2023","journal-title":"The Lancet"},{"issue":"10","key":"10.1016\/j.xops.2026.101287_bib105","doi-asserted-by":"crossref","first-page":"4487","DOI":"10.1007\/s00018-021-03796-9","article-title":"The complement system in age-related macular degeneration","volume":"78","author":"Armento","year":"2021","journal-title":"Cell Mol Life Sci CMLS"},{"issue":"19","key":"10.1016\/j.xops.2026.101287_bib106","doi-asserted-by":"crossref","first-page":"5555","DOI":"10.1093\/hmg\/ddv287","article-title":"A local complement response by RPE causes early-stage macular degeneration","volume":"24","author":"Fernandez-Godino","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"2","key":"10.1016\/j.xops.2026.101287_bib107","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/jama.2023.26074","article-title":"Age-Related macular degeneration: a review","volume":"331","author":"Fleckenstein","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.xops.2026.101287_bib108","first-page":"71","article-title":"Peculiar condition of choroiditis occurring in several members of the same family","volume":"19","author":"Doyne","year":"1899","journal-title":"Trans Ophthalmol Soc UK"},{"issue":"24","key":"10.1016\/j.xops.2026.101287_bib109","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.1091\/mbc.e11-08-0695","article-title":"Compromised mutant EFEMP1 secretion associated with macular dystrophy remedied by proteostasis network alteration","volume":"22","author":"Hulleman","year":"2011","journal-title":"Mol Biol Cell"},{"issue":"11","key":"10.1016\/j.xops.2026.101287_bib110","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1167\/iovs.05-0070","article-title":"Aberrant accumulation of Fibulin-3 in the endoplasmic reticulum leads to activation of the unfolded protein response and VEGF expression","volume":"46","author":"Roybal","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.xops.2026.101287_bib111","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/hmg\/ddt395","article-title":"Mouse genetics and proteomic analyses demonstrate a critical role for complement in a model of DHRD\/ML, an inherited macular degeneration","volume":"23","author":"Garland","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"20","key":"10.1016\/j.xops.2026.101287_bib112","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1093\/hmg\/ddm198","article-title":"The R345W mutation in EFEMP1 is pathogenic and causes AMD-like deposits in mice","volume":"16","author":"Fu","year":"2007","journal-title":"Hum Mol Genet"},{"issue":"7","key":"10.1016\/j.xops.2026.101287_bib113","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1167\/iovs.17-21720","article-title":"Mutant Fibulin-3 causes proteoglycan accumulation and impaired diffusion across Bruch's membrane","volume":"58","author":"Zayas-Santiago","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.xops.2026.101287_bib114","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1167\/iovs.65.6.31","article-title":"A long-term retrospective natural history Study of EFEMP1 -Associated Autosomal Dominant Drusen","volume":"65","author":"De Guimar\u00e3es","year":"2024","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2026.101287_bib115","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-3-319-95046-4_18","article-title":"Doyne honeycomb retinal dystrophy (Malattia leventinese, Autosomal Dominant Drusen)","volume":"1085","author":"Tsang","year":"2018","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"10.1016\/j.xops.2026.101287_bib116","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/hmg\/ddac187","article-title":"Complement factor B is critical for sub-RPE deposit accumulation in a model of Doyne honeycomb retinal dystrophy with features of age-related macular degeneration","volume":"32","author":"Crowley","year":"2022","journal-title":"Hum Mol Genet"},{"issue":"39","key":"10.1016\/j.xops.2026.101287_bib117","doi-asserted-by":"crossref","first-page":"E8214","DOI":"10.1073\/pnas.1710430114","article-title":"Drusen in patient-derived hiPSC-RPE models of macular dystrophies","volume":"114","author":"Galloway","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.xops.2026.101287_bib118","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/9722","article-title":"A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy","volume":"22","author":"Stone","year":"1999","journal-title":"Nat Genet"},{"issue":"7","key":"10.1016\/j.xops.2026.101287_bib119","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1167\/iovs.05-1600","article-title":"Maculopathy due to the R345W substitution in Fibulin-3: distinct clinical features, disease variability, and extent of retinal dysfunction","volume":"47","author":"Michaelides","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"10.1016\/j.xops.2026.101287_bib120","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1002\/humu.24452","article-title":"A loss-of-function cysteine mutant in fibulin-3 (EFEMP1) forms aberrant extracellular disulfide-linked homodimers and alters extracellular matrix composition","volume":"43","author":"Woodard","year":"2022","journal-title":"Hum Mutat"},{"key":"10.1016\/j.xops.2026.101287_bib121","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.547436","article-title":"EFEMP1 overexpression contributes to neovascularization in age-related macular degeneration","volume":"11","author":"Cheng","year":"2021","journal-title":"Front Pharmacol"},{"issue":"15","key":"10.1016\/j.xops.2026.101287_bib122","doi-asserted-by":"crossref","first-page":"8689","DOI":"10.3390\/ijms23158689","article-title":"The complement System, aging, and aging-related diseases","volume":"23","author":"Zheng","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.xops.2026.101287_bib123","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.3389\/fimmu.2018.02664","article-title":"Age and sex-associated changes of complement activity and complement levels in a healthy caucasian population","volume":"9","author":"Gaya da Costa","year":"2018","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.xops.2026.101287_bib124","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1001\/jamaophthalmol.2025.1608","article-title":"Dynamic risk of systemic complement activation with time to progression to advanced age-related macular degeneration","volume":"143","author":"Lynch","year":"2025","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.xops.2026.101287_bib125","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-3-319-17121-0_8","article-title":"Extracellular Matrix alterations and deposit Formation in AMD","volume":"854","author":"Fernandez-Godino","year":"2016","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"10.1016\/j.xops.2026.101287_bib126","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1001\/archopht.122.4.598","article-title":"Current concepts in the pathogenesis of age-related macular degeneration","volume":"122","author":"Zarbin","year":"2004","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"10.1016\/j.xops.2026.101287_bib127","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1097\/JS9.0000000000000477","article-title":"Celebrating a breakthrough: the first-ever FDA-approved treatment for geographic atrophy: a correspondence","volume":"109","author":"Khan","year":"2023","journal-title":"Int J Surg Lond Engl"},{"issue":"10411","key":"10.1016\/j.xops.2026.101287_bib128","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/S0140-6736(23)01583-0","article-title":"Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial","volume":"402","author":"Khanani","year":"2023","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.xops.2026.101287_bib129","series-title":"Approved drug products with therapeutic equivalence evaluations | Orange book. FDA [Internet]","year":"2025"},{"key":"10.1016\/j.xops.2026.101287_bib130","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1537974","article-title":"Factor B as a therapeutic target for the treatment of complement-mediated diseases","volume":"16","author":"Kavanagh","year":"2025","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.xops.2026.101287_bib131","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1167\/iovs.11-8585","article-title":"Laser-Mediated activation of human retinal pigment epithelial cells and concomitant release of matrix metalloproteinases","volume":"53","author":"Zhang","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.xops.2026.101287_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.apjo.2025.100143","article-title":"Triterpenoid saponin\u2013mediated recovery of visual deficits in age-related macular degeneration (AMD): Double-blind, placebo-controlled, randomised clinical trial","volume":"14","author":"Lee","year":"2025","journal-title":"Asia-Pac J Ophthalmol"},{"issue":"3","key":"10.1016\/j.xops.2026.101287_bib133","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s10555-019-09812-6","article-title":"Functional disparities within the TIMP family in cancer: hints from molecular divergence","volume":"38","author":"Eckfeld","year":"2019","journal-title":"Cancer Metastasis Rev"},{"issue":"2","key":"10.1016\/j.xops.2026.101287_bib134","first-page":"111","article-title":"Tissue inhibitors of metalloproteinases: structure, regulation and biological functions","volume":"74","author":"Gomez","year":"1997","journal-title":"Eur J Cell Biol"},{"key":"10.1016\/j.xops.2026.101287_bib135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.pmbts.2017.02.005","article-title":"Biochemical and biological attributes of matrix metalloproteinases","volume":"147","author":"Cui","year":"2017","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"3","key":"10.1016\/j.xops.2026.101287_bib136","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1124\/pharmrev.121.000349","article-title":"Matrix metalloproteinases: from molecular mechanisms to physiology, pathophysiology, and pharmacology","volume":"74","author":"Almeida","year":"2022","journal-title":"Pharmacol Rev"},{"issue":"7","key":"10.1016\/j.xops.2026.101287_bib137","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.3390\/ijms17071178","article-title":"Matrix metalloproteinases in non-neoplastic disorders","volume":"17","author":"Tokito","year":"2016","journal-title":"Int J Mol Sci"}],"container-title":["Ophthalmology Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914526002253?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914526002253?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T08:10:40Z","timestamp":1786954240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666914526002253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":137,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2666914526002253"],"URL":"https:\/\/doi.org\/10.1016\/j.xops.2026.101287","relation":{},"ISSN":["2666-9145"],"issn-type":[{"value":"2666-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interactions Between Epidermal Growth Factor\u2013Containing Fibulin-Like Extracellular Matrix Protein 1 and Tissue Inhibitor of Metalloproteinases-3 and Relevance to Age-Related Macular Degeneration","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xops.2026.101287","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Ophthalmology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101287"}}